Skip to content

Evaluation of serum replacement frequency used in drug infusion on serum contamination and incidence of phlebitis

Investigation the effect of the 24 and 48-hour changing in chloride sodium 0.9% used in infusion of drug on the amount of phlebitis and serum infection

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210307050610N1
Enrollment
300
Registered
2021-05-11
Start date
2021-05-22
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Phlebitis. Condition 2: Catheter-related infection. Vascular complications following a procedure, not elsewhere classified Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts

Interventions

Intervention 1: Intervention group: The serum used in the infusion of drugs will be changed every 48 hours. At the end of 48 hours from the start of serum infusion, 5 cc of each serum was drawn with a

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: People over the age of 18 patient consent or caregiver patient cooperation having a drug to be infused patients who have been hospitalized for at least 48 hours

Exclusion criteria

Exclusion criteria: Pregnant patients lactating patients immunocompromised patients Patients with skin and vascular diseases Patients receiving hypertonic serum and patients receiving blood and blood products patients receivingTotal parenteral nutrition Patients with sepsis patients with mental disorders Patients receiving anticoagulants If you have a local infection at the catheter injection site

Design outcomes

Primary

MeasureTime frame
Number of phlebitis according to Jackson criteria. Timepoint: During the period of hospitalization. Method of measurement: Jackson criteria.;Number of cases of serum contamination. Timepoint: 24 hours in the control group and 48 hours in the experimental group. Method of measurement: Response of serum culture sample sent to laboratory.

Secondary

MeasureTime frame
Number of catheter contamination cases. Timepoint: Discharge of the patient or 72 hours after catheter placement or catheter phlebitis. Method of measurement: Response of the catheter sample sent to the laboratory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHasan Khalili

Sabzevar University of Medical Sciences

khaalili894@gmail.com+98 51 4408 6458

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026